Literature DB >> 12836872

Identification of the inositol isomers present in Tetrahymena.

Michael C Kersting1, Michele Boyette, Joseph H Massey, Phillip E Ryals.   

Abstract

The inositol isomer composition of phosphoinositides, polyphosphoinositols, phosphatidylinositol-linked glycans, and glycosyl phosphatidylinositol-anchored proteins of logarithmic phase Tetrahymena vorax was determined by GC-MS analysis of trimethylsilylimadazole derivatives. The most abundant inositol found was the myo-isomer; however, appreciable percentages of scylloinositol were present in the free inositol pool, phosphatidylinositol-linked glycan fraction, and glycosyl phosphatidylinositol-anchored protein fraction. Trace quantities of chiro- and neo-inositols also were present.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12836872     DOI: 10.1111/j.1550-7408.2003.tb00111.x

Source DB:  PubMed          Journal:  J Eukaryot Microbiol        ISSN: 1066-5234            Impact factor:   3.346


  5 in total

Review 1.  Conservation and innovation in Tetrahymena membrane traffic: proteins, lipids, and compartments.

Authors:  Alejandro D Nusblat; Lydia J Bright; Aaron P Turkewitz
Journal:  Methods Cell Biol       Date:  2012       Impact factor: 1.441

2.  Trans-cyclization of phosphatidylinositol catalyzed by phospholipase C from Streptomyces antibioticus.

Authors:  Chuan Bai; Li Zhao; Mario Rebecchi; Ming-Daw Tsai; Karol S Bruzik
Journal:  J Am Chem Soc       Date:  2009-06-24       Impact factor: 15.419

Review 3.  Inositol polyphosphates: a new frontier for regulating gene expression.

Authors:  Abel R Alcázar-Román; Susan R Wente
Journal:  Chromosoma       Date:  2007-10-18       Impact factor: 4.316

4.  Properties of scyllo-inositol as a therapeutic treatment of AD-like pathology.

Authors:  Daniela Fenili; Mary Brown; Rebecca Rappaport; JoAnne McLaurin
Journal:  J Mol Med (Berl)       Date:  2007-02-06       Impact factor: 5.606

5.  Acyl chain selection couples the consumption and synthesis of phosphoinositides.

Authors:  Len R Stephens; Phillip T Hawkins; David Barneda; Vishnu Janardan; Izabella Niewczas; Daniel M Collins; Sabina Cosulich; Jonathan Clark
Journal:  EMBO J       Date:  2022-06-30       Impact factor: 14.012

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.